Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, May 22, 2025 · 815,012,783 Articles · 3+ Million Readers

Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation

/EIN News/ -- SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. (NYSE: DOCS) shareholders, concerning alleged misconduct by certain officers and directors that may have harmed the company and its investors. 

Investors who have continuously held Doximity shares since before June 24, 2021, may have legal rights and are encouraged to contact the firm to learn more: https://www.johnsonfistel.com/investigations/doximity-inc-2

On May 13, 2025, the Court overseeing the securities fraud class action against Doximity denied the defendants’ motion to dismiss. The Court found that the plaintiff had sufficiently alleged that, throughout the Class Period, the defendants made materially false and/or misleading statements and failed to disclose material adverse facts about the Company’s business and operations.

In particular, the Court found that plaintiffs plausibly alleged that Doximity misrepresented the number of active physician users on its platform and falsely claimed increasing user engagement, despite internal data and survey evidence suggesting otherwise. The complaint also alleges that defendants touted Doximity’s growth prospects and revenue sustainability, while downplaying challenges such as increased competition, tightening macroeconomic conditions, and the Company’s reliance on “upselling” advertising and services to existing clients.

If you would like to know more about your rights as a shareholder or how you can participate in holding the officers and directors responsible for the damage that they allegedly caused the company to suffer, please contact Johnson Fistel at (619) 814-4471.

About Johnson Fistel, PLLP | Top Law Firm, Securities Fraud, Investors Rights:
Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. We also extend our services to foreign investors who have purchased on US exchanges. Stay updated with news on stock drops and learn how Johnson Fistel, PLLP can help you recover your losses. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com.

Achievements: In 2024, Johnson Fistel was honored to be ranked in the Top 10 Plaintiff Law Firms by the ISS Securities Class Action Services. This recognition underscores our effectiveness in advocating for investors, having recovered approximately $90,725,000 for aggrieved clients in cases where we served as lead or co-lead counsel. This notable accomplishment marks the eighth occasion our firm has been recognized as a top plaintiffs’ securities law firm in the United States, as determined by the total dollar value of final recoveries.

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

Contact:
Johnson Fistel, PLLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com


Primary Logo

Powered by EIN News

Distribution channels: Business & Economy, Law ...

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release